Increased expression of hypothalamic leptin receptor and adiponectin accompany resistance to dietary-induced obesity and infertility in female C57BL/6J mice

International Journal of Obesity

Volumn 31, Issue 3, 2007, Pages 395-402

  Tortoriello, D V ^a,c   McMinn, J E ^a   Chua, S C ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

Adiponectin; DIO; Infertility; PAI 1

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; LEPTIN; LEPTIN RECEPTOR; NEUROPEPTIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; C57BL 6 MOUSE; CONTROLLED STUDY; FAT INTAKE; FEMALE; FEMALE INFERTILITY; FEMALE SUBFERTILITY; GENE EXPRESSION; GENE MUTATION; HORMONE RELEASE; HYPOTHALAMUS; INBRED STRAIN; LEAN BODY WEIGHT; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR GENE; WILD TYPE;

ADIPONECTIN; ANIMALS; BODY WEIGHT; DIETARY FATS; FEMALE; GONADOTROPIN-RELEASING HORMONE; HYPOTHALAMUS; INFERTILITY, FEMALE; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; NEUROPEPTIDE Y; OBESITY; PREGNANCY; PRO-OPIOMELANOCORTIN; RECEPTORS, CELL SURFACE; RESISTIN; TISSUE PLASMINOGEN ACTIVATOR;

MUS;

EID: 33847246881     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0803392     Document Type: Article

References (22)

1. Frederich RC, Lollmann B, Hamann A, Napolitano-Rosen A, Kahn BB, Lowell BB et al. Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J Clin Invest 1995; 96: 1658-1663.
2. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1995; 1: 1311-1314.
3. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-295.
4. Carlsson B, Lindell K, Gabrielsson B, Karlsson C, Bjarnason R, Westphal O et al. Obese (ob) gene defects are rare in human obesity. Obes Res 1997; 5: 30-35.
5. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115: 911-919; quiz 920.
6. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
7. Tortoriello DV, McMinn J, Chua SC. Dietary-induced obesity and hypothalamic infertility in female DBA/2J mice. Endocrinology 2004; 145: 1238-1247.
8. Lansang MC, Williams GH, Carroll JS. Correlation between the glucose clamp technique and the homeostasis model assessment in hypertension. Am J Hypertens 2001; 14: 51-53.
9. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402-2410.
10. El-Haschimi K, Lehnert H. Leptin resistance - or why leptin fails to work in obesity. Exp Clin Endocrinol Diabetes 2003; 111: 2-7.
11. Huang XF, Han M, South T, Storlien L. Altered levels of POMC, AgRP and MC4-R mRNA expression in the hypothalamus and other parts of the limbic system of mice prone or resistant to chronic high-energy diet-induced obesity. Brain Res 2003; 992: 9-19.
12. Huang XF, Han M, Storlien LH. The level of NPY receptor mRNA expression in diet-induced obese and resistant mice. Brain Res Mol Brain Res 2003; 115: 21-28.
13. Ravinet Trillou C, Arnone M, Delgorge C, Gonalons N, Keane P, Maffrand JP et al. Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am J Physiol Regul Integr Comp Physiol 2003; 284: R345-R353.
14. Lin S, Storlien LH, Huang XF. Leptin receptor, NPY, POMC mRNA expression in the diet-induced obese mouse brain. Brain Res 2000; 875: 89-95.
15. Agardh CD, Agardh E, Hultberg B, Ahren B. Long-standing hyperglycemia in C57BL/6J mice does not affect retinal glutathione levels or endothelial/pericyte ratio in retinal capillaries. J Diabetes Complications 2000; 14: 146-153.
16. De Taeye B, Smith LH, Vaughan DE. Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease. Curr Opin Pharmacol 2005; 5: 149-154.
17. Fay WP, Shapiro AD, Shih JL, Schleef RR, Ginsburg D. Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation. N Engl J Med 1992; 327: 1729-1733.
18. Chorostowska-Wynimko J, Skrzypczak-Jankun E, Jankun J. Plasminogen activator inhibitor type-1 controls the process of the in vitro sprout formation. J Physiol Pharmacol 2004; 55 (Suppl 3): 49-56.
19. Ma LJ, Mao SL, Taylor KL, Kanjanabuch T, Guan Y, Zhang Y et al. Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes 2004; 53: 336-346.
20. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005; 26: 439-451.
21. Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, Komeda K et al. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J Biol Chem 2001; 276: 41245-41254.
22. Qi Y, Takahashi N, Hileman SM, Patel HR, Berg AH, Pajvani UB et al. Adiponectin acts in the brain to decrease body weight. Nat Med 2004; 10: 524-529.